scholarly article | Q13442814 |
P2093 | author name string | Foster SJ | |
Aasen AO | |||
Almlöf M | |||
Jørgensen PF | |||
Okkenhaug C | |||
Scholz T | |||
Solberg R | |||
Thiemermann C | |||
Wang JE | |||
P2860 | cites work | A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. | Q53438021 |
Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. | Q105219584 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sirolimus | Q32089 |
whole blood | Q7997549 | ||
P304 | page(s) | 184-191 | |
P577 | publication date | 2001-02-01 | |
P1433 | published in | Scandinavian Journal of Immunology | Q15762682 |
P1476 | title | Sirolimus interferes with the innate response to bacterial products in human whole blood by attenuation of IL-10 production | |
P478 | volume | 53 |
Q50148782 | A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects |
Q33364817 | Benefit-risk assessment of sirolimus in renal transplantation |
Q37418402 | Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients |
Q33960631 | Cachexia: a therapeutic approach beyond cytokine antagonism |
Q44558476 | Cystic fibrosis liver disease: to transplant or not to transplant? |
Q40172570 | Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells |
Q43012576 | Fatal infection after rapamycin eluting coronary stent implantation |
Q38175673 | Immunostimulatory activity of lifespan-extending agents. |
Q80002078 | Immunosuppression using the mTOR inhibition mechanism affects replacement of rat liver with transplanted cells |
Q54191451 | Inhibition of LPS-induced inflammatory mediators by 3-hydroxyanthranilic acid in macrophages through suppression of PI3K/NF-κB signaling pathways. |
Q35690685 | Intrarenal abscesses due to Ureaplasma urealyticum in a transplanted kidney |
Q28364012 | Peptidoglycan and lipoteichoic acid modify monocyte phenotype in human whole blood |
Q28484885 | Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study |
Q37236661 | Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-alpha expression in macrophages by reducing IL-10 expression |
Q38592317 | Regulation of innate immune cell function by mTOR. |
Q34424858 | Role of the mTOR Pathway in LPS-Activated Monocytes: Influence of Hypertonic Saline |
Q51826534 | Serum interleukin-6 (IL-6) and IL-10 concentrations in normal and septic neonatal foals. |
Q53564914 | Successful surgical outcome of infected aneurysmal drug-coated stent endocarditis. |
Q80810342 | T-cell function monitoring in stable renal transplant patients treated with sirolimus monotherapy |
Q43919339 | The effect of LPS on neutrophils from patients with high risk of type 1 diabetes mellitus in relation to IL-8, IL-10 and IL-12 production and apoptosis in vitro |
Q38187336 | The emerging role of mTOR signalling in antibacterial immunity |
Search more.